Via Medica Journals
Not a member yet
55128 research outputs found
Sort by
The global rise of myopia and contemporary methods of slowing the progression of myopia in children and adolescents
No full textBACKGROUND: Myopia is of particular interest due to its prevalence, current epidemiology, and the possibility of progression of the defect. In this article, we wanted to show whether the rapid increase in the incidence of myopia has made it a serious public health problem.
MATERIAL AND METHODS: A review of literature from 2002–2022 in PubMed database was conducted. The study was designed according to the PRISMA 2020 flow diagram for new systematic reviews, which includes searches of databases and registers only. 187 articles were included in our final review.
RESULTS: Projections indicate that by 2050, 50% of people may have myopia (population 4.8 billion), and 9.8% may have high myopia. Optical interventions such as orthokeratological, and MiSight contact lens show a reduction in myopia progression. Promising results are derived from the use of defocus-incorporated multiple-segment lenses (DIMS). Results of combination therapy such as low concentration atropine (0.01%) plus orthokeratology lenses suggest that combination seems to be better than monotherapy.
CONCLUSIONS: New solutions that combine the correction of the defect myopia with the inhibition of progressive pathological changes in the eye give us great hope. The full correction of myopia is currently recommended to attain an optimal vision as the main aim.
Serpiginous choroiditis — difficult to diagnose, even more difficult to treat: a case report
No full textSerpiginous choroiditis (SC) is a rare inflammatory disease of the retina and uvea with an unknown pathomechanism, leading to permanent visual impairment. It usually affects healthy middle-aged men. The cause is unknown; the treatment is difficult and only symptomatic. It consists of the administration of glucocorticoids and immunosuppressive drugs. In the work, we present the case of a 36-year-old patient, her diagnostic and therapeutic process, and the difficulties in obtaining effective therapy. Currently, there are no guidelines for diagnostic procedures and treatment due to the rare occurrence of the disease, the unknown cause, and the lack of knowledge about triggering factors
Rationale and design of the administrative data and electronic medical records-based registry: The Cardiology Scientific Network of the Medical University of Silesia (CardioSilesia)
No full textDark papillary muscles: A new piece of the puzzle in understanding mechanical stretch injury associated with mitral annular disjunction
No full textRapid resolution of severe rheumatic mitral regurgitation following dapagliflozin and torasemide treatment
No full text
First in Poland Aveir VR leadless pacemaker implantation in a heart transplant recipient: Case report
No full text
Simultaneous use of extravascular implantable cardioverter-defibrillator and left ventricular pacing through the coronary sinus in a patient with a history of transcatheter edge-to-edge tricuspid valve repair
No full textNight light pollution and cardiovascular disease
No full textArtificial light at night (ALAN) is a significant environmental factor with negative effects on human health. Technological advances have significantly altered light exposure patterns, reducing access to natural light during the day and increasing exposure to artificial light during the evening and night hours. ALAN disrupts the circadian rhythm, mainly by suppressing melatonin, leading to endocrine and metabolic disorders and an increased risk of cardiovascular disease. Intrinsically photosensitive retinal ganglion cells, which modulate melatonin expression in response to light exposure, play an important role in initiating these processes. Measuring light exposure remains a challenge, despite the availability of methods such as satellite imagery and personal dosimetry. Emerging epidemiological evidence links night-time light pollution to the development of cardiovascular risk factors, including hypertension, obesity, diabetes, and atherosclerosis, as well as overt cardiovascular disease. The implications of this research suggest the implementation of measures to prevent the negative effects of ALAN by promoting exposure to bright light during the day and minimizing unnecessary lighting in the evening and at night through warm spectrum lighting, curfews, adaptive dimming systems, and dynamic smart lighting solutions. The integration of global strategies that change the urban approach to street and building lighting with individual behavior and the widespread use of smart lighting is essential to create healthier nighttime environments. Future research should further elucidate the dose-response relationships between specific lighting parameters and health outcomes, assess individual susceptibility, and evaluate the effectiveness of mitigation measures. Interdisciplinary collaboration of biologists, medical doctors, environmental scientists, and public health specialists is key to translating scientific evidence into preventive policies to reduce the health burden of nighttime light pollution